Abstract
Association of hypercholesterolemia and atherosclerotic cardiovascular disease (ASCVD) is well established. Reducing low-density lipoprotein-cholesterol (LDL-C) and raising high-density lipoprotein-cholesterol (HDL-C) have been the therapeutic targets to reduce the risk of ASCVD. Cholesterol-lowering medications have been used to provide both primary and secondary prevention of ASCVD for many years by reducing the absorption and reabsorption, promoting excretion, or decreasing the synthesis of cholesterol. Within the past five years, several new classes of cholesterol-lowering drugs have been tested and approved for patients with hypercholesterolemia that are not well controlled by conventional therapy (ezetimibe, bile-acid sequestrants, and statins). These drugs include proprotein convertase subtilisin/kexin type 9 (PCSK9) antibodies, apolipoprotein A-100 (Apo B-100) antisense, and microsomal triglyceride transfer protein (MTP) inhibitor. Clinical trials revealed that adding PCSK9 antibodies to the preexisting statin therapy can further reduce LDL-C by 60%. ApoB antisense and MTP inhibitor are currently approved for patients with homozygous familial hypercholesterolemia. Several HDL-raising drugs have also been tested, but the...Continue Reading
Citations
Jun 8, 2017·Children·Francesco Massimo PerlaCaterina Anania
Jan 19, 2018·Expert Review of Clinical Pharmacology·Julie Rask LarsenPeter Manu
Jan 25, 2018·Pharmacy : Journal of Pharmacy, Education and Practice·Donatella ZoddaSilvia Schifilliti
Dec 13, 2017·Expert Opinion on Drug Metabolism & Toxicology·Arrigo F G CiceroClaudio Borghi
Mar 27, 2018·Annals of Medicine·Najmeh AhangariAlireza Pasdar
Nov 6, 2018·International Journal of Molecular Sciences·Asier Benito-VicenteCesar Martin
Mar 20, 2019·Internal Medicine Journal·Yee-Ming CheungElif I Ekinci
Jan 5, 2020·Molecular Psychiatry·Eeva SlizZdenka Pausova
Jul 23, 2020·Frontiers in Pharmacology·Simona Codruta HeghesMirela Moldovan
Sep 21, 2018·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Massimo VolpeUNKNOWN Scientific Societies
Jun 12, 2020·Journal of Medicinal Food·Min-Jee KimHojun Kim
Feb 20, 2019·Lipids in Health and Disease·Chengfeng QiuBin Tang
Sep 20, 2018·Hormones : International Journal of Endocrinology and Metabolism·Niki Katsiki, Dimitri P Mikhailidis
May 12, 2018·Nutrients·Mikiko WatanabeCarla Lubrano
Oct 2, 2020·The Journal of Nutrition·Francois BlachierAnne Blais
Jan 23, 2021·PloS One·Ji Bak KimJin Won Kim
Oct 27, 2018·Journal of Natural Products·Giordano LesmaAlessandra Silvani